https://scholars.lib.ntu.edu.tw/handle/123456789/456377
標題: | The novel isoflavone 7-hydroxy-3′,4′-benzoisoflavone induces cell apoptosis in human osteosarcoma cells | 作者: | CHUN-HAN HOU Fong Y.-C. Chen J.-T. Liu J.-F. Lin M.-S. Chang C.-S. Tang C.-H. |
公開日期: | 2008 | 卷: | 271 | 期: | 1 | 起(迄)頁: | 117-128 | 來源出版物: | Cancer Letters | 摘要: | Osteosarcoma is the most frequent primitive malignant tumor of the skeletal system and is characterized by an extremely aggressive clinical course that lacks an effective treatment. This study is the first to investigate the anti-cancer effects of a new isoflavone-derived 7-hydroxy-3′,4′-benzoisoflavone (HBI) in human osteosarcoma cells. HBI-induced cell apoptosis in human osteosarcoma cell lines. The accumulation of reactive oxygen species (ROS) is a critical mediator in HBI induced cell death. HBI also induced apoptosis signal-regulating kinase 1 (ASK1) dephosphorylation, p38, JNK and p53 phosphorylation. Transfection with ASK1, p38 and JNK small interfering RNA (siRNA) antagonized HBI-induced cell apoptosis. HBI also triggered the mitochondrial apoptotic pathway, as indicated by a change in Bax/Bcl2 ratio. Bax knockdown using a Bax siRNA strategy reduced Bax expression and subsequent cell death. In addition, ASK1, p38 and JNK siRNA reduced HBI-induced p53 phosphorylation and Bax expression. These results suggest that the ROS-ASK1-p38/JNK-p53 and Bax pathway plays a critical role in HBI's anti-cancer effects. ? 2008 Elsevier Ireland Ltd. All rights reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-54849185600&doi=10.1016%2fj.canlet.2008.05.037&partnerID=40&md5=ad924ffb2f92beff55c6969d73cabe6e https://scholars.lib.ntu.edu.tw/handle/123456789/456377 |
ISSN: | 0304-3835 | DOI: | 10.1016/j.canlet.2008.05.037 | SDG/關鍵字: | 7 hydroxy 3',4' benzoisoflavone; alpha tubulin; apoptosis signal regulating kinase 1; catalase; cytochrome c; isoflavone derivative; protein Bax; protein bcl 2; protein p53; reactive oxygen metabolite; small interfering RNA; stress activated protein kinase; synaptophysin; unclassified drug; animal cell; antineoplastic activity; apoptosis; article; cancer cell culture; controlled study; human; human cell; mitochondrion; mouse; nonhuman; osteosarcoma cell; priority journal; protein dephosphorylation; protein expression; protein phosphorylation; Apoptosis; Cell Line, Tumor; Enzyme Activation; Flow Cytometry; Humans; In Situ Nick-End Labeling; Isoflavones; MAP Kinase Kinase 4; MAP Kinase Kinase Kinase 5; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Reactive Oxygen Species; Signal Transduction |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。